...
首页> 外文期刊>European journal of cancer care >Organization-based performance measures of cancer care quality: core measure development for breast cancer in Taiwan.
【24h】

Organization-based performance measures of cancer care quality: core measure development for breast cancer in Taiwan.

机译:基于组织的癌症护理质量绩效评估:台湾乳腺癌的核心评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of the study was to develop organization-based core performance measures (CPMs) for breast cancer patients treated in hospitals that participated in cancer quality improvement programmes in Taiwan. CPMs were developed in three stages that included a preparation, a consensus building stage, and two stages of stakeholder feedback. Three criteria and seven subcriteria were applied in the development process. Indicators listed in a Delphi questionnaire were based on a literature search, indicators developed by relevant institutions and discussion by authors. Each indicator needed to meet inclusion criteria as a final indicator. Evidence-based guidelines, expert opinions from panel group, 27 hospitals and empirical data were all applied to develop and revise the core measures. Fifteen out of 28 indicators were selected and modified after the three stages. There were two pre-treatment indicators for screening and diagnosis, nine treatment-related indicators, and four monitoring-related indicators. Six indicators were supported by evidence level I, and four indicators by level II evidence. The CPMs for breast cancer can be developed systematically and be applied for internal quality improvement and external surveillance. Our experience can be extended to other cancer sites and adapted to link with pay for performance or certification program in cancer care.
机译:这项研究的目的是为参加台湾癌症质量改善计划的医院治疗的乳腺癌患者制定基于组织的核心绩效指标(CPM)。 CPM分三个阶段制定,包括准备阶段,共识建立阶段和利益相关者反馈的两个阶段。在开发过程中应用了三个标准和七个子标准。 Delphi调查表中列出的指标是基于文献检索,相关机构制定的指标以及作者的讨论。每个指标都需要满足纳入标准作为最终指标。循证指南,专家小组的专家意见,27家医院和经验数据均被用于制定和修订核心指标。在三个阶段之后,选择并修改了28项指标中的15项。有两项用于筛查和诊断的治疗前指标,九项与治疗有关的指标和四项与监测有关的指标。 I级证据支持六个指标,II级证据支持四个指标。乳腺癌的CPM可以系统地开发,并可以用于内部质量改善和外部监测。我们的经验可以扩展到其他癌症场所,并可以与薪酬或癌症护理绩效计划挂钩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号